Diagnosing type 2 diabetes and identifying high-risk individuals using the new glycated haemoglobin (HbA1c) criteria

British Journal of General Practice

Volumn 63, Issue 607, 2013, Pages

  Gholap, Nitin N ^a   Davies, Melanie J ^a   Mostafa, Samiul A ^a   Khunti, Kamlesh ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ALGORITHM; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE DURATION; GLUCOSE BLOOD LEVEL; GOLD STANDARD; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PATIENT IDENTIFICATION; REPRODUCIBILITY; RISK ASSESSMENT; SENSITIVITY ANALYSIS;

ALGORITHMS; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; RISK ASSESSMENT; RISK FACTORS;

EID: 84873102490     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp13X663244     Document Type: Article

References (15)

1. Diabetes UK. State of diabetes care in the UK 2009. London: Diabetes UK, 2010.
2. Diabetes UK. Prediabetes: preventing the type 2 diabetes epidemic. A report. 2009. http://www.diabetes.org.uk/Documents/Reports/ PrediabetesPreventingtheType2diabetesepide micOct2009report.pdf (accessed 11 Jan 2013).
3. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Med 1998;15(7):539-553. (Pubitemid 28319935)
4. The International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32(7):1327-1334.
5. World Health Organization. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Abbreviated report of a WHO consultation. Geneva: WHO, 2011:1-25.
6. Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010;362(9):800-811.
7. John WG, Hillson R, Alberti SG. Use of haemoglobin A1c (HbA1c) in the diagnosis of diabetes mellitus. The implementation of World Health Organisation (WHO) guidance 2011. Practical Diabetes 2012;29:12-12a.
8. National Institute for Health and Clinical Excellence. Preventing type 2 diabetes - risk identification and interventions for individuals at high risk. Public Health Guidance 38. London: NICE, 2012. http://www.nice.org.uk/guidance/ ph38 (accessed 11 Jan 2013).
9. Gray LJ, Taub NA, Khunti K, et al. The Leicester Risk Assessment score for detecting undiagnosed type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting. Diabetic Med 2010;27(8):887-895.
10. Gray L, Davies M, Hiles S, et al. Detection of impaired glucose regulation and/or type 2 diabetes mellitus, using primary care electronic data, in a multiethnic UK community setting. Diabetologia 2012;55(4):959-966.
11. Griffin SJ, Little PS, Hales CN, et al. Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev 2000;16(3):164-171. (Pubitemid 30410271)
12. Eborall H, Stone M, Aujla N, et al. Influences on the uptake of diabetes screening: a qualitative study in primary care. Br J Gen Pract 2012; DOI:10.3399/bjgp12X630106.
13. Mostafa SA, Davies MJ, Webb D, et al. The potential impact of using glycated haemoglobin as the preferred diagnostic tool for detecting Type 2 diabetes mellitus. Diabetic Med 2010;27(7):762-769.
14. Colagiuri S, Lee C M Y, Wong TY, et al. Glycemic thresholds for diabetes-specific retinopathy. Diabetes Care 2011;34(1):145-150.
15. Al-Ansary L, Farmer A, Hirst J, et al. Point of-care testing for HbA1c in the management of diabetes: a systematic review and metaanalysis. Clin Chem 2011;57(4):568-576.